SE9603463D0 - New compounds - Google Patents

New compounds

Info

Publication number
SE9603463D0
SE9603463D0 SE9603463A SE9603463A SE9603463D0 SE 9603463 D0 SE9603463 D0 SE 9603463D0 SE 9603463 A SE9603463 A SE 9603463A SE 9603463 A SE9603463 A SE 9603463A SE 9603463 D0 SE9603463 D0 SE 9603463D0
Authority
SE
Sweden
Prior art keywords
new compounds
absorbable
methionine
cysteine
peptides
Prior art date
Application number
SE9603463A
Other languages
Swedish (sv)
Inventor
Haakan Bergstrand
Tomas Eriksson
Magnus Lindvall
Bengt Saernstrand
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9603463A priority Critical patent/SE9603463D0/en
Publication of SE9603463D0 publication Critical patent/SE9603463D0/en
Priority to AU44770/97A priority patent/AU4477097A/en
Priority to PCT/SE1997/001550 priority patent/WO1998012216A1/en

Links

Abstract

A physiologically active peptide of formula (I): A-R1-R2-R3-R4-B wherein each variable has the meaning defined in the description at least one of R1, R2 and R3 being methionine and at most one of R1, R2 and R3 being cysteine, the entire peptide sequence containing 3 to 30 amino acid residues. These peptides are absorbable by the epithelial cell lining in a mammal resulting in a modulated immune response and thereby a therapeutic effect against disease.
SE9603463A 1996-09-23 1996-09-23 New compounds SE9603463D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE9603463A SE9603463D0 (en) 1996-09-23 1996-09-23 New compounds
AU44770/97A AU4477097A (en) 1996-09-23 1997-09-15 Methionine containing peptides having immunomodulatory effect
PCT/SE1997/001550 WO1998012216A1 (en) 1996-09-23 1997-09-15 Methionine containing peptides having immunomodulatory effect

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9603463A SE9603463D0 (en) 1996-09-23 1996-09-23 New compounds

Publications (1)

Publication Number Publication Date
SE9603463D0 true SE9603463D0 (en) 1996-09-23

Family

ID=20403985

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9603463A SE9603463D0 (en) 1996-09-23 1996-09-23 New compounds

Country Status (3)

Country Link
AU (1) AU4477097A (en)
SE (1) SE9603463D0 (en)
WO (1) WO1998012216A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU9655698A (en) * 1997-10-10 1999-05-03 Astra Aktiebolag Synthetic genes with immunomodulatory effects

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5494672A (en) * 1989-04-28 1996-02-27 S.P.I. Synthetic Peptides Incorporated Pseudomonas peptide composition and method
WO1993024136A1 (en) * 1991-01-17 1993-12-09 Terman David S Tumor killing effects of enterotoxins, superantigens, and related compounds
EP0629213B1 (en) * 1992-03-07 1996-10-23 Morinaga Milk Industry Co., Ltd. Use of an immunostimulatory agent
US6696061B1 (en) * 1992-08-11 2004-02-24 President And Fellows Of Harvard College Immunomodulatory peptides
AUPM446594A0 (en) * 1994-03-16 1994-04-14 Csl Limited Cytotoxic t-cell epitopes identified within epstein-barr virus
CA2187336A1 (en) * 1994-04-08 1995-10-19 Henry M. Franzen Pharmaceutical formulations for treating japanese cedar pollen allergy
AP690A (en) * 1994-07-05 1998-10-16 Steeno Res Group A/S Immunomodulators based on a polypeptide other than human interleukin 10.
SE9403526D0 (en) * 1994-10-14 1994-10-14 Astra Ab New Peptides
EP0923604A1 (en) * 1996-04-12 1999-06-23 Astra Aktiebolag Cysteine-containing or methioine-containing peptides with immunomodulatory effects

Also Published As

Publication number Publication date
WO1998012216A1 (en) 1998-03-26
AU4477097A (en) 1998-04-14

Similar Documents

Publication Publication Date Title
DK2016950T3 (en) Pharmaceutical composition comprising an exendin-4 peptide
DE69435105D1 (en) Derivatives of therapeutic peptides
DK0719340T3 (en) Cloned glutamic acid decarboxylase
EP2327712A3 (en) Treatment of autoimmune conditions with copolymer 1 and related copolymers and peptides
DE69126568D1 (en) New physiologically active pig peptide (CNP-53)
RU94041224A (en) PEPTIDES WITH ORGAN-PROTECTIVE ACTIVITY, PHARMACEUTICAL COMPOSITION ON THEIR BASIS AND THEIR USE IN THERAPY
SE9403526D0 (en) New Peptides
TR200103339T2 (en) New LHRH-antagonists with improved solubility features.
DE69617396D1 (en) Peptides affecting T cells
SE9603468D0 (en) New compounds
SE9501067D0 (en) New peptides
DE68917837D1 (en) Peptide compounds.
KR960702754A (en) VAGINAL PREPARATION CONTAINING PHYSIOLOGICALLY ACTIVE PEPTIDE containing physiologically active peptides
DE69409237T2 (en) ORAL, PHARMACEUTICAL COMPOSITIONS CONTAINING A PROTEIN OR PEPTIDE, AN ANTIBODY AND POLYMER BALLS
DK1154786T3 (en) Compositions for modulating mucus secretion
SE9603463D0 (en) New compounds
SE9603461D0 (en) New compounds
SE9603466D0 (en) New compounds
SE9603462D0 (en) New compounds
ATE371737T1 (en) PROTEAS RESISTANT FLINT ANALOGUE
TR200200599T2 (en) Human insulin monomeric analogues.
DE69837145D1 (en) SELECTION MARKER
ATE69240T1 (en) MITOGENIC PEPTIDES.
MX9605651A (en) New peptides with immunomodulatory effects.
ECSP972139A (en) INTERFERON CONJUGATES (CASE RAN 410077)